The second color Booster COVID-19: Do I need to get one?

ACurrently, the drug COVID-19 is available for one year in the U.S. But the films are not designed to protect against infection with SARS-CoV-2, and the protection produced by the vaccines is reduced, therefore the disease persists. change and become changeable – and destroy what is fixed. Coupling with another form of cancer can further increase immunity, so public health officials approved an initial booster shot for most people last year. But as new forms of the disease continue, it’s time to consider a new booster for the general public. Now, that second enhancer has been suggested for some people to be more COVID-19 patients who could benefit from the improved immunity provided by the new shot.

Experts are not happy with the idea of ​​adding booster after booster of the same disease. So they began research to see if there was a better way to improve medications, and if the current methods of shots were the best to rely on in the face of a chronic illness. . Here is what we know now.

Who can get a second boost?

For most banks in the U.S., getting your COVID-19 medications now means getting the medication, and then getting a booster dose a few months later. . For Pfizer-BioNTech or Moderna shots, it includes two primary sources and a stimulant; if you’re protected with a Johnson & Johnson-Janssen shot, it’s one of the first illnesses and motivators.

Children from 12 to 17 years old can exercise, but only with the Pfizer-BioNtech shot; Moderna and Johnson & Johnson promoters are not allowed for this age group.

For some people, such as those over 50 and people with health conditions that make it difficult for them to put in a strong immune response, health officials said a second booster later. four months after the first. That, in part, is based on data from Israel, which reported adding a second booster in January for people over 60 and for health care workers, said reduces the risk of death from severe COVID-19.

At a recent Food and Drug Administration (FDA) meeting of independent advisory committee members, experts reviewed research looking at the potential benefits of adding a disease booster. For example, they looked at research showing a decline in the protection made by the first exercise after a few months – studies from Israel show that chronic illness is starting to rise. among those who were encouraged, while they remained lower than the number of those who were not encouraged. . They also considered lab -related studies from the U.S. that verified levels of antibodies that fight viral infections produced after the onset of a large booster after another. months, falling about six times at a time.

In addition, the added benefits of the latter should be weighed against side effects, including inflammation of the heart muscle, especially for young people taking Pfizer-BioNTech and Moderna medications. and blood pressure problems for those with J&J. pana. That means continuing to increase it every four months or so with different vaccines is a way to keep COVID-19 at bay, even if the disease continues to mutate.

After considering all the available studies, the committee decided that there was not enough data to support the promotion of a second public incentive. Although a secondary stimulant can raise the levels of a person’s antibodies against COVID-19, and protect them from serious illness, the protection is not always as desired by health officials. So for the vast majority of the U.S. population, that double increase is unnecessary – not right now.

If I am approved, when will I get a second incentive?

Currently, people who are likely to have a second booster disease include those over 50 years of age and some groups of people who are weak in their immune systems. If you are immunocompromised and you are receiving Pfizer-BioNTech medication as a first dose (i.e. three seasons), as well as a boost, you may now be able to get a second dose. exertion, or five, four months after the first exertion if 12 years or older. ancient. If you are immunocompromised and you have the current vaccine as a primary vaccine and primary stimulant, you may be able to get a second physical activity if you are 18 years of age or older.

A second booster should not prevent you from getting SARS-CoV-2, but if you do get the disease, it can reduce your chance of getting seriously ill and going to bed. the hospital for symptoms related to COVID-19.

At what point will the rest of the population have a double boost?

When it came to the rest of the population, the situation was unclear. There is no doubt that it increases antibody levels. Antibodies have been well documented to be important, although they are not the only contributor to a strong immune system against SARS-CoV-2. Studies of each patient show that the COVID-19 vaccines currently approved build the human T-cell response-a group of immune systems that remember specific cancer cells and live in being ready the next time they meet them. In fact, research shows that T-cells can protect against disease and protect people from serious illness if they get the disease. Understanding how well a second supplement increases this T-cell response can help health officials determine if that new supplement is necessary for people who are not at high risk. of chronic disease – the T -cell response, of course, now. under scientific research.

Scientists are now trying to answer by figuring out how strong the vaccine response is, how long it will take to prevent it, and if current vaccination is the best way. to do. Currently, the images used as a stimulant are similar to those of the original drug, and have not been shown to induce antibody levels that are higher than those after the drug. the first booster.

Do I have to wait for a different motivational shot?

To date, the promoters have had another form of primary cancer. But with newer varieties such as Omicron and its subtype BA.2 now being responsible for new allergies, health professionals are considering switching to the COVID-19 vaccine, according to How they switch to influenza patients each year for vaccination.

The pharmaceutical manufacturers behind the most sophisticated pharmaceuticals to date have developed and are testing new controls for beta, Delta, and Omicron strains. These groups are trying to combine these shots to find a combination that can be used as a motivator to produce a long -term and broad -based natural response. But the results from these studies won’t be available until the summer in the first place, so health officials can’t say any new incentives for the large U.S. population until the review. Those consequences are inevitable.

Currently, only a few groups are eligible for a double booster, because they have a higher risk of developing serious illness if they have epilepsy, even if printed and enlarged. The rest of us are confined and expanded, making personal decisions about continuing to wear masks in public places, and to avoid places where we interact with a lot of people, to pursue the best way to limit our knowledge. and the COVID -19 problem – at least until more data are available.

Must Read Stories from TIME


Contact us ma [email protected]

Related Posts

Leave a Reply

Your email address will not be published.